genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model [Yahoo! Finance]
Innate Pharma S.A. - American Depositary Shares (IPHA)
Company Research
Source: Yahoo! Finance
However, many promising drug candidates fail in clinical trials. A study in Science Immunology shows that genOway's genO-hFc?R mouse model enables more accurate prediction of therapeutic antibody efficacy and safety. genOway: Revolutionizing the Prediction of Antibody Therapies in Humans with Unique Mouse Model Why Antibody Therapies Fail in Late-Stage Testing Antibody therapies work in part by binding to Fc? receptors, proteins found on immune cells that control key immune functions such as antibody-mediated cell killing and inflammation. Since these receptors are different between species, human therapies tested in standard laboratory mice give unreliable efficacy results or miss potential safety risks. These discrepancies cause expensive late-stage failures and slow patient access to new therapies. A New Mouse Model with Humanized Fc? Receptors Set to Become a Gamechanger A new study published in Science Immunology showed that an innovative mouse model developed by genOwa
Show less
Read more
Impact Snapshot
Event Time:
IPHA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IPHA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IPHA alerts
High impacting Innate Pharma S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IPHA
News
- Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026 [Yahoo! Finance]Yahoo! Finance
- Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026Business Wire
- Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Innate Pharma to Participate in the Leerink Partners Global Healthcare ConferenceBusiness Wire
- Innate Pharma (NASDAQ:IPHA) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat